Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$98.96 AUD
Change Today +2.61 / 2.71%
Volume 3.2M
CSL On Other Exchanges
Symbol
Exchange
OTC US
Munich
OTC US
Frankfurt
As of 2:11 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John Shine AO, FAA, Ph.D., BSc

Chairman, Chairman of Nomination Committee and Member of Innovation & Development Committee, CSL Ltd.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 4 different industries.

See Board Relationships
69$537,925

Background*

Professor John Shine, Ao FAA, Ph.D., BSc, serves as the Chief Executive Officer of Garvan Chairman of Institute of Medical Research. Prof. Shine is a Professor of Molecular Biology and Professor of Medicine at the University of NSW. He serves as Secretary (Biological Sciences) of the Australian Academy of Science. He is an Australian molecular biology and biotechnology pioneer. He has been the Chairman of CSL Ltd. since October 19, 2011 and serves as its a Non Executive ...

Read Full Background

Corporate Headquarters*

45 Poplar Road
Parkville, Victoria 3052

Australia

Phone: 61 3 9389 1911
Fax: 61 3 9389 1434

Board Members Memberships*

Director
2006-Present
Chairman, Chairman of Nomination Committee and Member of Innovation & Development Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$537,925
Total Calculated Compensation$537,925
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSL:AU A$98.96 AUD +2.61

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Pierre Clamadieu Chief Executive Officer, Director and Member of Finance Committee
Solvay SA
€2.5M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Victor Grifols Roura Chairman, Chief Executive Officer, President and Member of Appointments & Remuneration Committee
Grifols, S.A.
--
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥182.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSL LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.